202 related articles for article (PubMed ID: 21909466)
1. Grafting using injectable calcium sulfate in bone tumor surgery: comparison with demineralized bone matrix-based grafting.
Kim JH; Oh JH; Han I; Kim HS; Chung SW
Clin Orthop Surg; 2011 Sep; 3(3):191-201. PubMed ID: 21909466
[TBL] [Abstract][Full Text] [Related]
2. The effect of demineralized bone matrix-calcium sulfate with vancomycin on calcaneal fracture healing and infection rates: a prospective study.
Bibbo C; Patel DV
Foot Ankle Int; 2006 Jul; 27(7):487-93. PubMed ID: 16842714
[TBL] [Abstract][Full Text] [Related]
3. Osseous healing using injectable calcium sulfate-based putty for the delivery of demineralized bone matrix and cancellous bone chips.
Turner TM; Urban RM; Hall DJ; Infanger S; Gitelis S; Petersen DW; Haggard WO
Orthopedics; 2003 May; 26(5 Suppl):s571-5. PubMed ID: 12755228
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an injectable chitosan-demineralized bone matrix hybrid for healing critical-size long-bone defects in a rabbit model.
Shuang F; Hou SX; Zhao YT; Zhong HB; Xue C; Zhu JL; Bu GY; Cao Z
Eur Rev Med Pharmacol Sci; 2014; 18(5):740-52. PubMed ID: 24668718
[TBL] [Abstract][Full Text] [Related]
5. The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial.
Kelly CM; Wilkins RM; Gitelis S; Hartjen C; Watson JT; Kim PT
Clin Orthop Relat Res; 2001 Jan; (382):42-50. PubMed ID: 11154003
[TBL] [Abstract][Full Text] [Related]
6. Treatment of benign bone lesions with an injectable calcium sulfate-based bone graft substitute.
Kelly CM; Wilkins RM
Orthopedics; 2004 Jan; 27(1 Suppl):s131-5. PubMed ID: 14763545
[TBL] [Abstract][Full Text] [Related]
7. Healing of large defects treated with calcium sulfate pellets containing demineralized bone matrix particles.
Urban RM; Turner TM; Hall DJ; Infanger S; Cheema N; Lim TH
Orthopedics; 2003 May; 26(5 Suppl):s581-5. PubMed ID: 12755230
[TBL] [Abstract][Full Text] [Related]
8. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis.
Martin GJ; Boden SD; Titus L; Scarborough NL
Spine (Phila Pa 1976); 1999 Apr; 24(7):637-45. PubMed ID: 10209791
[TBL] [Abstract][Full Text] [Related]
9. Efficacy comparison of Accell Evo3 and Grafton demineralized bone matrix putties against autologous bone in a rat posterolateral spine fusion model.
Brecevich AT; Kiely PD; Yoon BV; Nguyen JT; Cammisa FP; Abjornson C
Spine J; 2017 Jun; 17(6):855-862. PubMed ID: 28126356
[TBL] [Abstract][Full Text] [Related]
10. Function after injection of benign bone lesions with a bioceramic.
Fillingham YA; Lenart BA; Gitelis S
Clin Orthop Relat Res; 2012 Jul; 470(7):2014-20. PubMed ID: 22290129
[TBL] [Abstract][Full Text] [Related]
11. Effect of a calcium sulfate implant with calcium sulfate barrier on periodontal healing in 3-wall intrabony defects in dogs.
Kim CK; Kim HY; Chai JK; Cho KS; Moon IS; Choi SH; Sottosanti JS; Wikesjö UM
J Periodontol; 1998 Sep; 69(9):982-8. PubMed ID: 9776026
[TBL] [Abstract][Full Text] [Related]
12. Bioassayed demineralized bone matrix and calcium sulfate: use in bone-grafting procedures.
Wilkins RM; Kelly CM; Giusti DE
Ann Chir Gynaecol; 1999; 88(3):180-5. PubMed ID: 10532559
[TBL] [Abstract][Full Text] [Related]
13. Aqueous calcium sulphate as bone graft for voids following open curettage of bone tumours.
Johnson LJ; Clayer M
ANZ J Surg; 2013 Jul; 83(7-8):564-70. PubMed ID: 22925525
[TBL] [Abstract][Full Text] [Related]
14. Demineralized Bone Matrix Carriers and their Clinical Applications: An Overview.
Zhang H; Yang L; Yang XG; Wang F; Feng JT; Hua KC; Li Q; Hu YC
Orthop Surg; 2019 Oct; 11(5):725-737. PubMed ID: 31496049
[TBL] [Abstract][Full Text] [Related]
15. Natural Course of Local Bone Mineralization After Treatment of Benign or Borderline Bone Tumors and Cysts With a Composite Ceramic Bone Graft Substitute.
Horstmann PF; Hettwer WH; Petersen MM
J Clin Densitom; 2018; 21(4):472-479. PubMed ID: 29661685
[TBL] [Abstract][Full Text] [Related]
16. Use of a calcium sulfate-based bone graft substitute for benign bone lesions.
Gitelis S; Piasecki P; Turner T; Haggard W; Charters J; Urban R
Orthopedics; 2001 Feb; 24(2):162-6. PubMed ID: 11284599
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of tibial plateau fractures with an injectable bone substitute: CERAMENT™. Three year follow-up from a prospective study.
Iundusi R; Gasbarra E; D'Arienzo M; Piccioli A; Tarantino U
BMC Musculoskelet Disord; 2015 May; 16():115. PubMed ID: 25968241
[TBL] [Abstract][Full Text] [Related]
18. Injectable Synthetic Beta-Tricalcium Phosphate/Calcium Sulfate (GeneX) for the Management of Contained Defects Following Curettage of Benign Bone Tumours.
Razii N; Docherty LM; Halai M; Mahendra A; Gupta S
Curr Oncol; 2023 Mar; 30(4):3697-3707. PubMed ID: 37185394
[TBL] [Abstract][Full Text] [Related]
19. The use of demineralized bone matrix for grafting during Le Fort I and chin osteotomies: techniques and complications.
Lye KW; Deatherage JR; Waite PD
J Oral Maxillofac Surg; 2008 Aug; 66(8):1580-5. PubMed ID: 18634943
[TBL] [Abstract][Full Text] [Related]
20. Long-term Follow-up of the Use of a Synthetic Bone Graft Composite in the Surgical Management of Primary Bone Tumors.
Multani I; Schneider P; Baldawi H; Deheshi B; Ghert M
Orthopedics; 2018 Nov; 41(6):e868-e875. PubMed ID: 30371921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
